 | • レポートコード：QYR9N7232 • 出版社/出版日：QYResearch / 2019年6月14日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、97ページ • 納品方法：Eメール（受注後２～3営業日） • 産業分類：医療・製薬・バイオ |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当資料は、一般的な腫瘍治療薬のグローバル市場について調査・分析したレポートで、種類別（大分子薬、小分子薬）、用途別（病院薬局、小売薬局、オンライン薬局）、主要地域別（アメリカ、ヨーロッパ、中国、日本、東南アジア、インド、中南米）の市場規模、市場予測、関連企業情報などが含まれています。 ・一般的な腫瘍治療薬の世界市場規模 ・主要企業別市場シェア ・一般的な腫瘍治療薬の世界市場規模：種類別（大分子薬、小分子薬） ・一般的な腫瘍治療薬の世界市場規模：用途別（病院薬局、小売薬局、オンライン薬局） ・一般的な腫瘍治療薬のアメリカ市場規模（種類別、用途別） ・一般的な腫瘍治療薬のヨーロッパ市場規模（種類別、用途別） ・一般的な腫瘍治療薬の中国市場規模（種類別、用途別） ・一般的な腫瘍治療薬の日本市場規模（種類別、用途別） ・一般的な腫瘍治療薬の東南アジア市場規模（種類別、用途別） ・一般的な腫瘍治療薬のインド市場規模（種類別、用途別） ・一般的な腫瘍治療薬の中南米市場規模（種類別、用途別） ・主要企業別分析（企業概要、製品動向、販売量など） ・一般的な腫瘍治療薬の世界市場予測（2019年-2025年） ・一般的な腫瘍治療薬の地域別市場予測（2019年-2025年） ... |
In 2018, the global Generic Oncology Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.
This report focuses on the global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Generic Oncology Drugs development in United States, Europe and China.
The key players covered in this study
Pfizer
GlaxoSmithKline
Novartis
Merck
Celgene
Teva Pharmaceutical
Mylan
Aurobindo Pharma
Hikma Pharmaceuticals
Natco Pharma
Market segment by Type, the product can be split into
Large Molecule Drugs
Small Molecule Drugs
Market segment by Application, split into
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Market segment by Regions/Countries, this report covers
United States
Europe
China
Japan
Southeast Asia
India
Central & South America
The study objectives of this report are:
To analyze global Generic Oncology Drugs status, future forecast, growth opportunity, key market and key players.
To present the Generic Oncology Drugs development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.
In this study, the years considered to estimate the market size of Generic Oncology Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Generic Oncology Drugs Market Size Growth Rate by Type (2014-2025)
1.4.2 Large Molecule Drugs
1.4.3 Small Molecule Drugs
1.5 Market by Application
1.5.1 Global Generic Oncology Drugs Market Share by Application (2014-2025)
1.5.2 Hospital Pharmacies
1.5.3 Retail Pharmacies
1.5.4 Online Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Generic Oncology Drugs Market Size
2.2 Generic Oncology Drugs Growth Trends by Regions
2.2.1 Generic Oncology Drugs Market Size by Regions (2014-2025)
2.2.2 Generic Oncology Drugs Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Generic Oncology Drugs Market Size by Manufacturers
3.1.1 Global Generic Oncology Drugs Revenue by Manufacturers (2014-2019)
3.1.2 Global Generic Oncology Drugs Revenue Market Share by Manufacturers (2014-2019)
3.1.3 Global Generic Oncology Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Generic Oncology Drugs Key Players Head office and Area Served
3.3 Key Players Generic Oncology Drugs Product/Solution/Service
3.4 Date of Enter into Generic Oncology Drugs Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Generic Oncology Drugs Market Size by Type (2014-2019)
4.2 Global Generic Oncology Drugs Market Size by Application (2014-2019)
5 United States
5.1 United States Generic Oncology Drugs Market Size (2014-2019)
5.2 Generic Oncology Drugs Key Players in United States
5.3 United States Generic Oncology Drugs Market Size by Type
5.4 United States Generic Oncology Drugs Market Size by Application
6 Europe
6.1 Europe Generic Oncology Drugs Market Size (2014-2019)
6.2 Generic Oncology Drugs Key Players in Europe
6.3 Europe Generic Oncology Drugs Market Size by Type
6.4 Europe Generic Oncology Drugs Market Size by Application
7 China
7.1 China Generic Oncology Drugs Market Size (2014-2019)
7.2 Generic Oncology Drugs Key Players in China
7.3 China Generic Oncology Drugs Market Size by Type
7.4 China Generic Oncology Drugs Market Size by Application
8 Japan
8.1 Japan Generic Oncology Drugs Market Size (2014-2019)
8.2 Generic Oncology Drugs Key Players in Japan
8.3 Japan Generic Oncology Drugs Market Size by Type
8.4 Japan Generic Oncology Drugs Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Generic Oncology Drugs Market Size (2014-2019)
9.2 Generic Oncology Drugs Key Players in Southeast Asia
9.3 Southeast Asia Generic Oncology Drugs Market Size by Type
9.4 Southeast Asia Generic Oncology Drugs Market Size by Application
10 India
10.1 India Generic Oncology Drugs Market Size (2014-2019)
10.2 Generic Oncology Drugs Key Players in India
10.3 India Generic Oncology Drugs Market Size by Type
10.4 India Generic Oncology Drugs Market Size by Application
11 Central & South America
11.1 Central & South America Generic Oncology Drugs Market Size (2014-2019)
11.2 Generic Oncology Drugs Key Players in Central & South America
11.3 Central & South America Generic Oncology Drugs Market Size by Type
11.4 Central & South America Generic Oncology Drugs Market Size by Application
12 International Players Profiles
12.1 Pfizer
12.1.1 Pfizer Company Details
12.1.2 Company Description and Business Overview
12.1.3 Generic Oncology Drugs Introduction
12.1.4 Pfizer Revenue in Generic Oncology Drugs Business (2014-2019)
12.1.5 Pfizer Recent Development
12.2 GlaxoSmithKline
12.2.1 GlaxoSmithKline Company Details
12.2.2 Company Description and Business Overview
12.2.3 Generic Oncology Drugs Introduction
12.2.4 GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2014-2019)
12.2.5 GlaxoSmithKline Recent Development
12.3 Novartis
12.3.1 Novartis Company Details
12.3.2 Company Description and Business Overview
12.3.3 Generic Oncology Drugs Introduction
12.3.4 Novartis Revenue in Generic Oncology Drugs Business (2014-2019)
12.3.5 Novartis Recent Development
12.4 Merck
12.4.1 Merck Company Details
12.4.2 Company Description and Business Overview
12.4.3 Generic Oncology Drugs Introduction
12.4.4 Merck Revenue in Generic Oncology Drugs Business (2014-2019)
12.4.5 Merck Recent Development
12.5 Celgene
12.5.1 Celgene Company Details
12.5.2 Company Description and Business Overview
12.5.3 Generic Oncology Drugs Introduction
12.5.4 Celgene Revenue in Generic Oncology Drugs Business (2014-2019)
12.5.5 Celgene Recent Development
12.6 Teva Pharmaceutical
12.6.1 Teva Pharmaceutical Company Details
12.6.2 Company Description and Business Overview
12.6.3 Generic Oncology Drugs Introduction
12.6.4 Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2014-2019)
12.6.5 Teva Pharmaceutical Recent Development
12.7 Mylan
12.7.1 Mylan Company Details
12.7.2 Company Description and Business Overview
12.7.3 Generic Oncology Drugs Introduction
12.7.4 Mylan Revenue in Generic Oncology Drugs Business (2014-2019)
12.7.5 Mylan Recent Development
12.8 Aurobindo Pharma
12.8.1 Aurobindo Pharma Company Details
12.8.2 Company Description and Business Overview
12.8.3 Generic Oncology Drugs Introduction
12.8.4 Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
12.8.5 Aurobindo Pharma Recent Development
12.9 Hikma Pharmaceuticals
12.9.1 Hikma Pharmaceuticals Company Details
12.9.2 Company Description and Business Overview
12.9.3 Generic Oncology Drugs Introduction
12.9.4 Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2014-2019)
12.9.5 Hikma Pharmaceuticals Recent Development
12.10 Natco Pharma
12.10.1 Natco Pharma Company Details
12.10.2 Company Description and Business Overview
12.10.3 Generic Oncology Drugs Introduction
12.10.4 Natco Pharma Revenue in Generic Oncology Drugs Business (2014-2019)
12.10.5 Natco Pharma Recent Development
13 Market Forecast 2019-2025
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2019-2025)
13.10 Market Size Forecast by Application (2019-2025)
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
Table Generic Oncology Drugs Key Market Segments
Table Key Players Generic Oncology Drugs Covered
Table Global Generic Oncology Drugs Market Size Growth Rate by Type 2014-2025 (Million US$)
Figure Global Generic Oncology Drugs Market Size Market Share by Type 2014-2025
Figure Large Molecule Drugs Figures
Table Key Players of Large Molecule Drugs
Figure Small Molecule Drugs Figures
Table Key Players of Small Molecule Drugs
Table Global Generic Oncology Drugs Market Size Growth by Application 2014-2025 (Million US$)
Figure Hospital Pharmacies Case Studies
Figure Retail Pharmacies Case Studies
Figure Online Pharmacies Case Studies
Figure Generic Oncology Drugs Report Years Considered
Table Global Generic Oncology Drugs Market Size 2014-2025 (Million US$)
Figure Global Generic Oncology Drugs Market Size and Growth Rate 2014-2025 (Million US$)
Table Global Generic Oncology Drugs Market Size by Regions 2014-2025 (Million US$)
Table Global Generic Oncology Drugs Market Size by Regions 2014-2019 (Million US$)
Table Global Generic Oncology Drugs Market Share by Regions 2014-2019
Figure Global Generic Oncology Drugs Market Share by Regions 2014-2019
Figure Global Generic Oncology Drugs Market Share by Regions 2019
Table Market Top Trends
Table Global Generic Oncology Drugs Revenue by Manufacturers (2014-2019) (Million US$)
Table Global Generic Oncology Drugs Market Share by Manufacturers (2014-2019)
Figure Global Generic Oncology Drugs Market Share by Manufacturers in 2018
Table Global Generic Oncology Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Generic Oncology Drugs Product/Solution/Service
Table Date of Enter into Generic Oncology Drugs Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table Global Generic Oncology Drugs Market Size Share by Type (2014-2019)
Figure Global Generic Oncology Drugs Market Size Market Share by Type (2014-2019)
Table Global Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table Global Generic Oncology Drugs Market Size Share by Application (2014-2019)
Figure Global Generic Oncology Drugs Market Size Market Share by Application (2014-2019)
Figure Global Generic Oncology Drugs Revenue Market Share by Application in 2018
Figure United States Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table United States Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table United States Key Players Generic Oncology Drugs Market Share (2018-2019)
Table United States Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table United States Generic Oncology Drugs Market Share by Type (2014-2019)
Table United States Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table United States Generic Oncology Drugs Market Share by Application (2014-2019)
Figure Europe Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table Europe Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table Europe Key Players Generic Oncology Drugs Market Share (2018-2019)
Table Europe Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table Europe Generic Oncology Drugs Market Share by Type (2014-2019)
Table Europe Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table Europe Generic Oncology Drugs Market Share by Application (2014-2019)
Figure China Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table China Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table China Key Players Generic Oncology Drugs Market Share (2018-2019)
Table China Generic Oncology Drugs Market Size by Type (2014-20189) (Million US$)
Table China Generic Oncology Drugs Market Share by Type (2014-2019)
Table China Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table China Generic Oncology Drugs Market Share by Application (2014-2019)
Figure Japan Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table Japan Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table Japan Key Players Generic Oncology Drugs Market Share (2018-2019)
Table Japan Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table Japan Generic Oncology Drugs Market Share by Type (2014-2019)
Table Japan Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table Japan Generic Oncology Drugs Market Share by Application (2014-2019)
Figure Southeast Asia Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table Southeast Asia Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table Southeast Asia Key Players Generic Oncology Drugs Market Share (2018-2019)
Table Southeast Asia Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table Southeast Asia Generic Oncology Drugs Market Share by Type (2014-2019)
Table Southeast Asia Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table Southeast Asia Generic Oncology Drugs Market Share by Application (2014-2019)
Figure India Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table India Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table India Key Players Generic Oncology Drugs Market Share (2018-2019)
Table India Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table India Generic Oncology Drugs Market Share by Type (2014-2019)
Table India Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table India Generic Oncology Drugs Market Share by Application (2014-2019)
Figure Central & South America Generic Oncology Drugs Market Size 2014-2019 (Million US$)
Table Central & South America Key Players Generic Oncology Drugs Revenue (2018-2019) (Million US$)
Table Central & South America Key Players Generic Oncology Drugs Market Share (2018-2019)
Table Central & South America Generic Oncology Drugs Market Size by Type (2014-2019) (Million US$)
Table Central & South America Generic Oncology Drugs Market Share by Type (2014-2019)
Table Central & South America Generic Oncology Drugs Market Size by Application (2014-2019) (Million US$)
Table Central & South America Generic Oncology Drugs Market Share by Application (2014-2019)
Table Pfizer Company Details
Table Pfizer Revenue in Generic Oncology Drugs Business (2014-2019) (Million US$)
Figure Pfizer Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Pfizer Recent Development
Table GlaxoSmithKline Company Details
Table GlaxoSmithKline Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure GlaxoSmithKline Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table GlaxoSmithKline Recent Development
Table Novartis Company Details
Table Novartis Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Novartis Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Novartis Recent Development
Table Merck Company Details
Table Merck Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Merck Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Merck Recent Development
Table Celgene Company Details
Table Celgene Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Celgene Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Celgene Recent Development
Table Teva Pharmaceutical Company Details
Table Teva Pharmaceutical Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Teva Pharmaceutical Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Teva Pharmaceutical Recent Development
Table Mylan Company Details
Table Mylan Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Mylan Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Mylan Recent Development
Table Aurobindo Pharma Company Details
Table Aurobindo Pharma Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Aurobindo Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Aurobindo Pharma Recent Development
Table Hikma Pharmaceuticals Company Details
Table Hikma Pharmaceuticals Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Hikma Pharmaceuticals Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Hikma Pharmaceuticals Recent Development
Table Natco Pharma Company Details
Table Natco Pharma Revenue in Generic Oncology Drugs Business (2014-2019)(Million US$)
Figure Natco Pharma Revenue Growth Rate in Generic Oncology Drugs Business (2014-2019)
Table Natco Pharma Recent Development
Table Global Generic Oncology Drugs Market Size by Regions (Million US$) 2019-2025
Figure Global Generic Oncology Drugs Market Size Share by Regions (2019-2025)
Figure Global Generic Oncology Drugs Market Size Share by Regions in 2025
Figure United States Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Europe Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure China Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Japan Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Southeast Asia Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure India Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Figure Central & South America Generic Oncology Drugs Market Size Forecast (2019-2025)(Million USD)
Table Global Generic Oncology Drugs Market Size by Product (2019-2025) (Million US$)
Figure Global Generic Oncology Drugs Market Size by Product (2019-2025)
Figure Global Generic Oncology Drugs Market Size by Product in 2025
Table Global Generic Oncology Drugs Market Size by Application (2019-2025) (Million US$)
Figure Global Generic Oncology Drugs Market Size by Application (2019-2025)
Figure Global Generic Oncology Drugs Market Size by Application in 2025
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources
世界の炎症性皮膚疾患薬市場：市場規模・現状・予測 In 2018, the global Inflammatory Skin Diseases Drugs market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025. This report focuses on the global Inflammatory Skin Diseases Drugs status, future forecast, growth opportunity, key …- 世界の神経因性疼痛治療薬市場：市場規模・現状・予測 Neuropathic pain is pain caused by damage or disease affecting the somatosensory nervous system. Neuropathic pain may be associated with abnormal sensations called dysesthesia or pain from normally non-painful stimuli (allodynia).In terms of value, North America is a large market and is expected to …
- 世界のレビー小体型認知症薬市場：市場規模・現状・予測 Lewy body dementia (LBD, sometimes referred to as Lewy body disorder) is an umbrella term that includes Parkinson's disease dementia (PDD) and dementia with Lewy bodies (DLB), two dementias characterized by abnormal deposits of the protein alpha-synuclein in the brain.In 2018, the global Lewy Body D…
- 世界の悪性中皮腫薬市場：市場規模・現状・予測 Mesothelioma is a type of cancer that develops from the thin layer of tissue that covers many of the internal organs (known as the mesothelium).Our research indicates that the hospital pharmacies distribution channel segment is expected to witness a significant rise in revenue share over the forecas…
- 世界のグラム陽性菌感染症治療薬市場：市場規模・現状・予測 Gram-positive bacteria are those that are stained dark blue or violet by Gram staining. They are a major class of bacteria that cause various infections in humans.In 2018, the global Gram-positive Bacterial Infection Drugs market size was xx million US$ and it is expected to reach xx million US$ by …